These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20961784)

  • 1. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.
    Firnhaber C; Smeaton L; Saukila N; Flanigan T; Gangakhedkar R; Kumwenda J; La Rosa A; Kumarasamy N; De Gruttola V; Hakim JG; Campbell TB
    Int J Infect Dis; 2010 Dec; 14(12):e1088-92. PubMed ID: 20961784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Risk of Anemia, Neutropenia, and Thrombocytopenia in People With Human Immunodeficiency Virus and Well-Controlled Viral Replication.
    Akdag D; Knudsen AD; Thudium RF; Kirkegaard-Klitbo DM; Nielsen C; Brown P; Afzal S; Nordestgaard BG; Lundgren J; Nielsen SD
    J Infect Dis; 2019 Oct; 220(11):1834-1842. PubMed ID: 31414119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological abnormalities in HIV-infected patients.
    De Santis GC; Brunetta DM; Vilar FC; Brandão RA; de Albernaz Muniz RZ; de Lima GM; Amorelli-Chacel ME; Covas DT; Machado AA
    Int J Infect Dis; 2011 Dec; 15(12):e808-11. PubMed ID: 21880530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.
    Tuboi SH; Brinkhof MW; Egger M; Stone RA; Braitstein P; Nash D; Sprinz E; Dabis F; Harrison LH; Schechter M
    J Acquir Immune Defic Syndr; 2007 May; 45(1):52-9. PubMed ID: 17460471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
    Zhou J; Jaquet A; Bissagnene E; Musick B; Wools-Kaloustian K; Maxwell N; Boulle A; Wehbe F; Masys D; Iriondo-Perez J; Hemingway-Foday J; Law M;
    J Int AIDS Soc; 2012 Jan; 15(1):5. PubMed ID: 22289654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.
    Robertson K; Kumwenda J; Supparatpinyo K; Jiang JH; Evans S; Campbell TB; Price RW; Murphy R; Hall C; Marra CM; Marcus C; Berzins B; Masih R; Santos B; Silva MT; Kumarasamy N; Walawander A; Nair A; Tripathy S; Kanyama C; Hosseinipour M; Montano S; La Rosa A; Amod F; Sanne I; Firnhaber C; Hakim J; Brouwers P;
    J Neurovirol; 2011 Oct; 17(5):438-47. PubMed ID: 21786076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.
    Kyeyune R; Saathoff E; Ezeamama AE; Löscher T; Fawzi W; Guwatudde D
    BMC Infect Dis; 2014 Sep; 14():496. PubMed ID: 25209550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy.
    Semba RD; Shah N; Vlahov D
    J Acquir Immune Defic Syndr; 2001 Apr; 26(4):315-9. PubMed ID: 11317071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological Abnormalities of Adult HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia: A Cross-Sectional Study.
    Damtie S; Workineh L; Kiros T; Eyayu T; Tiruneh T
    HIV AIDS (Auckl); 2021; 13():477-484. PubMed ID: 33976573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in HIV-infected patients receiving highly active antiretroviral therapy.
    Moore RD; Forney D
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):54-7. PubMed ID: 11782590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.
    Venter WDF; Majam M; Akpomiemie G; Arulappan N; Moorhouse M; Mashabane N; Chersich MF
    BMC Public Health; 2017 Jul; 17(Suppl 3):445. PubMed ID: 28832288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world.
    Safren SA; Hendriksen ES; Smeaton L; Celentano DD; Hosseinipour MC; Barnett R; Guanira J; Flanigan T; Kumarasamy N; Klingman K; Campbell T
    AIDS Behav; 2012 Feb; 16(2):266-77. PubMed ID: 21499794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
    Hoffmann CJ; Fielding KL; Charalambous S; Sulkowski MS; Innes C; Thio CL; Chaisson RE; Churchyard GJ; Grant AD
    AIDS; 2008 Jan; 22(1):67-74. PubMed ID: 18090393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.
    Braitstein P; Boulle A; Nash D; Brinkhof MW; Dabis F; Laurent C; Schechter M; Tuboi SH; Sprinz E; Miotti P; Hosseinipour M; May M; Egger M; Bangsberg DR; Low N;
    J Womens Health (Larchmt); 2008; 17(1):47-55. PubMed ID: 18240981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.
    Tuboi SH; Pacheco AG; Harrison LH; Stone RA; May M; Brinkhof MW; Dabis F; Egger M; Nash D; Bangsberg D; Braitstein P; Yiannoutsos CT; Wood R; Sprinz E; Schechter M;
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):70-7. PubMed ID: 20035163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hematological abnormalities and malnutrition in HIV-infected under five children in Enugu.
    Ezeonwu BU; Ikefuna AN; Oguonu T; Okafor HU
    Niger J Clin Pract; 2014; 17(3):303-8. PubMed ID: 24714007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.
    Berhane K; Karim R; Cohen MH; Masri-Lavine L; Young M; Anastos K; Augenbraun M; Watts DH; Levine AM
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1245-52. PubMed ID: 15385731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial.
    Bouldouyre MA; Charreau I; Marchou B; Tangre P; Katlama C; Morlat P; Meiffredy V; Vittecoq D; Bierling P; Aboulker JP; Molina JM;
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):531-7. PubMed ID: 19855285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.